|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Plasma matrix metal- loproteinase-9,tissue inhibitor of metalloproteinase-2,and CD40 ligand levels in patients with stable coronary artery dis- ease显示文摘 | Tayebjee M H Lip G Y Tan K T | 2005 | Am J Cardiol2005，96，3： | 1 |
| 2 | Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation:a randomized,controlled trial of ablation strategies (the CFAE AF Trial)显示文摘 | Hunter R J Diab I Tayebjee M | | 0，，5： | 1 |
| 3 | Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)显示文摘 | TAYEBJEE M H NADAR S BLANN A D | 2004 | AmJ Hypertens2004，17，： | 1 |
| 4 | Circulating endothelial cells,von Willebrand factor,intedeukin-6,and prognosis in patients with acute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 5 | Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)显示文摘 | Tayebjee M H Nadar S Blann A D | 2004 | Am J Hypertens2004，17，9： | 1 |
| 6 | Collateralization and the response to obstruction of epicardial coronary arteries显示文摘 | Tayebjee M H Lip G Y MacFadyen R J | 2004 | QJM2004，97，5： | 1 |
| 7 | Extracellularmatrix biology: a new frontier in linking the pathology and therapy of hypentension 显示文摘 | TAYEBJEE M H MACFADYEN R J LIP G Y | 2003 | J Hypertens2003，21，12： | 1 |
| 8 | Cirolating endothelial cells,von Willebrand factor,interleukin-6,and prognosis in patients with acute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 9 | Circulating endothelial cells,von Willebrand factor,interleukin-6,and prognosis in patients with acute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | | 0，，02： | 1 |
| 10 | Plasma matrix metalloproteinase-9,tissue inhibitor of metalloproteinase-2,and CD40 ligand levels in patients with stable coronary artery disease显示文摘 | TAYEBJEE M H LIP G Y TAN K T | 2005 | Am J Cardiol2005，96，： | 1 |
| 11 | Matrixmetalloproteinase-9 and tissue inhibitor of metal oproteinase-1in hypertension and their relationship to cardiovascular risk andtreatment:a substudy of the Anglo-Scandinavian Cardiac OutcomesTrial (ASCOT)显示文摘 | TAYEBJEE M H NADAR S BLANN A D | 2009 | Am J Hyperterm2009，17，9： | 1 |
| 12 | Circulating endothelial cells,von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes 显示文摘 | Lip GY Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 13 | Circulating endothelial cells, yon Willebrand factor, interleukin-6, and prognosis in patients with aeute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 14 | Circulating endothelial cells,van Willebrand factor,interleukin-6,and prognosis in patients with acute coronary syndromes 显示文摘 | Lee KW lip GY Tayebjee M | 2005 | Blood2005，105，： | 1 |
| 15 | Circulating endothelial cells,von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes 显示文摘 | Lee KW Lip GY Tayebjee M | 2005 | Blood2005，105，： | 1 |
| 16 | Circulating endothelial cells, von Willebrand factor, interleukin 6, and prognosis in patients with acute coronary syndromes显示文摘 | Lee K W Lip G Y Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 17 | Extracellular matrix biology:a new frontier in linking the pathology and therapy of hypertension显示文摘 | Tayebjee M H MacFadyen RJ Lip G Y | 2003 | Hypertension2003，21，12： | 1 |
| 18 | Circulating endothelial cells,von Willebrand factor,interleukin-6,and prognosis in patients with acute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | | 0，，02： | 1 |
| 19 | Circulating endothelial cells, yon Willebrand factor, interleu- kin-6, and prognosis in patients with acute coronary syndromes显示文摘 | Lee KW Lip GY Tayebjee M | 2005 | Blood2005，105，2： | 1 |
| 20 | Target organ damage in hypertension:pathophysiology and implications for drug therapy显示文摘 | NADAR S K TAYEBJEE M H MESSERLI F | 2006 | Curr Pharm Des2006，12，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员